📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections. (2021)

First Author: Gale R

Attributed to: Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bjophthalmol-2020-317306

PubMed Identifier: 32962992

Publication URI: http://europepmc.org/abstract/MED/32962992

Type: Journal Article/Review

Volume: 105

Parent Publication: The British journal of ophthalmology

Issue: 11

ISSN: 0007-1161